F Outlook Therapeutics, Inc. Transaction History

F

  • $2.83 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024
BUY
$0.22 - $0.66 $2,200 - $6,600
10,000 Added 100.0%
20,000 $7,000
Q3 2022

Nov 04, 2022
BUY
$1.02 - $1.26 $10,200 - $12,600
10,000 New
10,000 $12,000
Q2 2022

Jul 20, 2022
SELL
$0.91 - $2.01 $9,100 - $20,099
-10,000 Closed
0 $0
Q1 2022

Apr 22, 2022
BUY
$1.22 - $2.03 $12,200 - $20,299
10,000 New
10,000 $17,000

Others Institutions Holding OTLK

# of Institutions
3
Shares Held
31.5K
Call Options Held
0
Put Options Held
0
View Full List

About Outlook Therapeutics, Inc.

OTLK Quotes by TradingView
  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.17B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track F Portfolio

Follow F and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of F, based on Form 13F filings with the SEC.

News

Stay updated on F with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email